Sponsor:
University of North Carolina, Chapel Hill
Code:
NCT06740162
Conditions
Intellectual Disability
Neurodevelopmental Disorders
Autism Spectrum Disorder
Down Syndrome
Fragile X Syndrome
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
PACE Program
Brief summary:
Conditions
Intellectual Disability
Neurodevelopmental Disorders
Autism Spectrum Disorder
Down Syndrome
Fragile X Syndrome
Study ID
NCT06740162
Start date
Jan 10, 2025
Status verified date
Feb, 2026
Completion date
Jun, 2028
Anticipated
Primary completion date
Dec, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
376 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: PACE Program
no intervention: Waitlist Control
Interventions
PACE Program
Primary outcome measure
Central contacts
Locations
University of North Carolina
Recruiting
Chapel Hill, North Carolina, United States, 27517
Contacts
Principal Investigator:
Brianne R Tomaszewski, Ph.D., MPH
Sponsor
University of North Carolina, Chapel Hill
Last update posted
Feb 23, 2026
Last verified
Feb, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by University of North Carolina, Chapel Hill on 2026-02-23.